134 related articles for article (PubMed ID: 37741763)
1. Long-term Outcomes After Hematopoietic Cell Transplant in Peripheral T-Cell Lymphoma - The Oregon Health and Science University Experience.
Galligan D; Williamson S; Myers J; Chen AI; Hayes-Lattin B; Okada C; Spurgeon S; Maziarz R; Schachter L
Clin Lymphoma Myeloma Leuk; 2023 Dec; 23(12):874-881. PubMed ID: 37741763
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Allogeneic and Autologous Hematopoietic Cell Transplantation for High-Risk Peripheral T Cell Lymphomas: A Retrospective Analysis From a Chinese Center.
Huang H; Jiang Y; Wang Q; Guo L; Jin Z; Fu Z; Han Y; Sun A; Liu W; Ruan J; Wu D
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1393-1397. PubMed ID: 28478121
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Rogers AM; Brammer JE
Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018.
Valcarcel B; Schonfeld SJ; Meyer CL; Brunson A; Cooley JJP; Abrahão R; Wun T; Auletta JJ; Gadalla SM; Engels E; Albert PS; Spellman SR; Rizzo JD; Shaw BE; Muffly L; Keegan THM; Morton LM
Transplant Cell Ther; 2024 Feb; 30(2):239.e1-239.e11. PubMed ID: 37981238
[TBL] [Abstract][Full Text] [Related]
5. Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL.
Kameda K; Kako S; Kim SW; Usui Y; Kato K; Fukuda T; Uchida N; Kobayashi H; Wakayama T; Sakaida E; Yano S; Imada K; Nara M; Ikeda T; Fuchida SI; Ishikawa J; Sugahara H; Kanda J; Kimura T; Ichinohe T; Atsuta Y; Kondo E
Leukemia; 2022 May; 36(5):1361-1370. PubMed ID: 35347237
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
Smith SM; Burns LJ; van Besien K; Lerademacher J; He W; Fenske TS; Suzuki R; Hsu JW; Schouten HC; Hale GA; Holmberg LA; Sureda A; Freytes CO; Maziarz RT; Inwards DJ; Gale RP; Gross TG; Cairo MS; Costa LJ; Lazarus HM; Wiernik PH; Maharaj D; Laport GG; Montoto S; Hari PN
J Clin Oncol; 2013 Sep; 31(25):3100-9. PubMed ID: 23897963
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.
Fenske TS; Ahn KW; Graff TM; DiGilio A; Bashir Q; Kamble RT; Ayala E; Bacher U; Brammer JE; Cairo M; Chen A; Chen YB; Chhabra S; D'Souza A; Farooq U; Freytes C; Ganguly S; Hertzberg M; Inwards D; Jaglowski S; Kharfan-Dabaja MA; Lazarus HM; Nathan S; Pawarode A; Perales MA; Reddy N; Seo S; Sureda A; Smith SM; Hamadani M
Br J Haematol; 2016 Jul; 174(2):235-48. PubMed ID: 26989808
[TBL] [Abstract][Full Text] [Related]
8. Transplantation.
Zain J
Cancer Treat Res; 2019; 176():269-287. PubMed ID: 30596223
[TBL] [Abstract][Full Text] [Related]
9. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Shustov A
Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.
Chen AI; McMillan A; Negrin RS; Horning SJ; Laport GG
Biol Blood Marrow Transplant; 2008 Jul; 14(7):741-7. PubMed ID: 18541192
[TBL] [Abstract][Full Text] [Related]
11. Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA; Kumar A; Ayala E; Hamadani M; Reimer P; Gisselbrecht C; d'Amore F; Jantunen E; Ishida T; Bazarbachi A; Foss F; Advani R; Fenske TS; Lazarus HM; Friedberg JW; Aljurf M; Sokol L; Tobinai K; Tse E; Burns LJ; Chavez JC; Reddy NM; Suzuki R; Ahmed S; Nademanee A; Mohty M; Gopal AK; Fanale MA; Pro B; Moskowitz AJ; Sureda A; Perales MA; Carpenter PA; Savani BN
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1826-1838. PubMed ID: 28797780
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis.
Hamadani M; Gopal AK; Pasquini M; Kim S; Qiu X; Ahmed S; Lazaryan A; Bhatt VR; Daly A; Lulla P; Ciurea S; Gauthier J; Agrawal V; Grover NS; Lekakis L; Modi D; Dahi PB; Herr MM; Johnson PC; Hashmi H; Hematti P; Locke FL
Blood Adv; 2022 Jan; 6(2):486-494. PubMed ID: 34673903
[TBL] [Abstract][Full Text] [Related]
13. Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.
Prochazka V; Faber E; Raida L; Vondrakova J; Kucerova L; Jarosova M; Indrak K; Papajik T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):63-6. PubMed ID: 19365529
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts.
Adrianzen Herrera D; Kornblum N; Derman O; Bachier-Rodriguez L; Sica RA; Shastri A; Janakiram M; Verma A; Braunschweig I; Mantzaris I
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):516-521. PubMed ID: 31227357
[TBL] [Abstract][Full Text] [Related]
15. Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics.
Hamadani M; Ngoya M; Sureda A; Bashir Q; Litovich CA; Finel H; Chen Y; Boumendil A; Zain J; Castagna L; Cashen AF; Blaise D; Shadman M; Pastano R; Khimani F; Arat M; Dietrich S; Schmitz N; Glass B; Kharfan-Dabaja MA; Corradini P; Sauter CS; Montoto S; Kwon M; Herrera AF; Dreger P
Blood Adv; 2022 Feb; 6(3):920-930. PubMed ID: 34861680
[TBL] [Abstract][Full Text] [Related]
16. Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Othman T; Quan MA; Zhang S; Gaut D; Young PA; Mahmood O; Abdulhaq H; Shieh K; Reid J; Brem EA; Hariharan N; Heyman B; Tuscano J
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):749-756. PubMed ID: 37336714
[TBL] [Abstract][Full Text] [Related]
17. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
Gkotzamanidou M; Papadimitriou CA
Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of allogeneic or autologous hematopoietic stem cell transplant for high-risk peripheral T cell lymphomas].
Wang QL; Huang HW; Jin ZM; Tang XW; Qiu HY; Fu CC; Han Y; Miao M; Chang HR; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):952-956. PubMed ID: 27995879
[TBL] [Abstract][Full Text] [Related]
19. Autologous hematopoietic cell transplantation for AML in first remission - An abandoned practice or promising approach?
Yeshurun M; Wolach O
Semin Hematol; 2019 Apr; 56(2):139-146. PubMed ID: 30926090
[TBL] [Abstract][Full Text] [Related]
20. Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis.
Czyz A; Romejko-Jarosinska J; Helbig G; Knopinska-Posluszny W; Poplawska L; Piatkowska-Jakubas B; Hawrylecka D; Nasilowska-Adamska B; Dytfeld D; Lojko-Dankowska A; Kopinska A; Boguradzki P; Walewski J; Kyrcz-Krzemien S; Hellmann A; Komarnicki M
Ann Hematol; 2013 Jul; 92(7):925-33. PubMed ID: 23471671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
